Dr. Anshul Gupta
Experience: Over 15 years
Indraprastha Apollo Hospitals, Sarita Vihar, New Delhi (Also at Apollo Hospitals, Noida)
New Delhi, India
Introduction
Dr. Anshul Gupta does medical oncology at Indraprastha Apollo. Patients show up when biopsy-confirmed cancer and treatment planning needs to start, or someone just wants a second opinion before committing to a treatment plan that will define the next year of their life.
About Dr. Anshul Gupta
Dr. Anshul Gupta has fifteen years of experience in deciding which drugs go into which cancer patient and in what sequence. ESMO certified, which means his clinical practice meets international European standards, not just domestic ones.
Did an international preceptorship in lung cancer from Australia’s only public hospital, entirely dedicated to cancer. Also holds a palliative medicine certification from the Indian Association of Palliative Care. That detail often gets skimmed over on paper, but it matters enormously in real life. He got trained and served as a senior resident in oncology at both AIIMS and Safdarjung.
Qualifications
- MBBS — Maulana Azad Medical College, Delhi.
- MD (Internal Medicine) — UCMS, Delhi.
- DM (Medical Oncology) — AIIMS, New Delhi.
- ESMO Certified Medical Oncologist.
- Lung Cancer Preceptorship — Peter MacCallum Cancer Centre, Melbourne.
- Palliative Medicine — IAPC Certified.
Awards & Recognition
- DM Medical Oncology from AIIMS.
- ESMO certified.
- Trained at Peter MacCallum, Melbourne.
- Co-principal investigator of international immunotherapy trials.
- Previously at AIIMS and Safdarjung.
- Member of ASCO, ESMO, ISMPO, and ISL.
Specialities & Expertise
- Breast and lung cancer treatment
- Genitourinary cancer management
- GI cancer and sarcoma treatment
- Immunotherapy
- Targeted therapy
- Leukemia, lymphoma, and myeloma care
- Palliative medicine
- Pain management
- Clinical trial participation
Patient Experience & Approach
Patients say the first consultation doesn’t rush toward treatment. Full molecular profiling gets discussed before any drug gets ordered because two breast cancers or two lung cancers can behave completely differently based on their genetic mutations, and treating them identically makes no sense. Cancer patients who also needed palliative support say pain and symptom management ran alongside active treatment rather than being treated as giving up.